Neurent Medical

NEU is an Enterprise Ireland (EI) funded start-up medical device company, developing novel radiofrequency (RF) ablation solutions for a range of ENT conditions. The company was formed based on the BioInnovate Programme at NUIG (a licenced version of Stanford’s BioDesign programme), which involves immersing experienced engineers in a clinical environment to identify unmet clinical needs with significant market potential. Moreover, NEU is developing a novel therapy to treat allergic and non-allergic rhinitis. NEU has invented a radically new bio-electric treatment modality to interrupt the inflammatory mediated response to the mucosal tissue of the nasal cavity. They have completed design and early development of their primary device with positive bench and in-vivo pre‐clinical evaluations. They have raised a Series A funding round to bring their first product through regulatory approval and early clinical trials.

NEU is an early stage medical device company with in-house R&D competencies and capabilities; pertinent to the design and development of a complex disposable electrically active medical device and a custom design RFG.